Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ARPINE BARSEGIAN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1780070649
CMS profile
6478738
Location
FOUNTAIN VALLEY, CA

General Payments · PY2019–2024

$9,040.28

  • Reported across 56 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,415.76

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alcon Laboratories Inc $2,068.96 4
Sight Sciences, Inc. $156.04 1
BIOTISSUE HOLDINGS INC. $47.30 2
ABBVIE INC. $32.46 1
Amgen Inc. $29.61 1
Bausch & Lomb Americas Inc. $22.89 1
Thea Pharma Inc. $21.32 1
GLAUKOS CORPORATION $21.20 1
RxSight Inc $15.98 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $495.36 8
PY2020 $125.89 1
PY2021 $536.66 11
PY2022 $751.92 16
PY2023 $4,714.69 7
PY2024 $2,415.76 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.46 06/27/2024 Food and Beverage Undisputed 01/23/2026 1103285079 CMS
Alcon Vision LLC $20.72 10/24/2024 Food and Beverage Undisputed 01/23/2026 1110651983 CMS
Alcon Vision LLC $120.72 11/07/2024 Food and Beverage Undisputed 01/23/2026 1110651985 CMS
Alcon Vision LLC $2.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 1110651981 CMS
Alcon Vision LLC $1,925.00 12/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1110526295 CMS
Amgen Inc. $29.61 10/03/2024 Food and Beverage Undisputed 01/23/2026 1111525272 CMS
Bausch & Lomb Americas Inc. $22.89 12/18/2024 Food and Beverage Undisputed 01/23/2026 1140305698 CMS
BIOTISSUE HOLDINGS INC. $23.65 10/31/2024 Food and Beverage Undisputed 01/23/2026 1148786061 CMS
BIOTISSUE HOLDINGS INC. $23.65 12/09/2024 Food and Beverage Undisputed 01/23/2026 1148787214 CMS
Glaukos Corporation $21.20 09/27/2024 Food and Beverage Undisputed 01/23/2026 1151986360 CMS
RxSight Inc $15.98 10/31/2024 Food and Beverage Undisputed 01/23/2026 1144212692 CMS
Sight Sciences, Inc. $156.04 03/21/2024 Food and Beverage Undisputed 01/23/2026 1151923257 CMS
Thea Pharma Inc. $21.32 09/13/2024 Food and Beverage Undisputed 01/23/2026 1074539329 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.